{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:34:29Z","timestamp":1768278869678,"version":"3.49.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>It is unclear whether AL amyloidoma of the skin\/subcutis represents a distinct entity, an indolent precursor of systemic amyloidosis, or a manifestation of cutaneous marginal zone lymphoma (cMZL). We collected 10 cases of cutaneous AL amyloidoma in order to better characterize the clinicopathologic features of this elusive entity (M:F=4:6; median age: 62.5 y, range: 31 to 82 y). Nine patients had a solitary nodule or plaque on the lower extremity (n=7), upper extremity (n=1), or chin (n=1). One patient had an AL amyloidoma on the right thigh and a second lesion on the right arm showing histopathologic features of cMZL without amyloid deposits. Clinical investigations excluded relevant systemic disease in all cases. Microscopically, dermal\/subcutaneous deposits of amyloid were associated with sparse to moderate perivascular infiltrates of lymphocytes and monotypic plasma cells (7 with kappa and 3 with lambda light chain restriction). The plasma cells expressed CD56 in one of 9 studied cases. One case was characterized by a t(14;18)(q32;q21)\/<jats:italic toggle=\"yes\">IGH-MALT1<\/jats:italic> translocation. Follow-up was available in 8 cases. All remain systemically well after a median time of 86.5 months (range: 40 to 144 mo). Local recurrence of disease was observed in 3 patients. A fourth patient presented with a cMZL without amyloid deposits 8 years after excision of the cutaneous AL amyloidoma. Although our series is small, careful categorization and follow-up of the cases, together with updated information in the literature, show clinical and biological links between AL amyloidomas of the skin\/subcutis and cMZL, suggesting that at least a subset of cutaneous AL amyloidoma may represent an unusual manifestation of cMZL (cutaneous mucosa-associated lymphoid tissue lymphomas).<\/jats:p>","DOI":"10.1097\/pas.0000000000000861","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T14:27:04Z","timestamp":1494685624000},"page":"1069-1076","source":"Crossref","is-referenced-by-count":37,"title":["AL Amyloidoma of the Skin\/Subcutis"],"prefix":"10.1097","volume":"41","author":[{"given":"Noreen M.","family":"Walsh","sequence":"first","affiliation":[{"name":"Pathology"},{"name":"Medicine, Nova Scotia Health Authority (Central Zone)"},{"name":"Department of Pathology, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian Marie","family":"Lano","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Green","sequence":"additional","affiliation":[{"name":"Medicine, Nova Scotia Health Authority (Central Zone)"},{"name":"Department of Pathology, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Gallant","sequence":"additional","affiliation":[{"name":"Medicine, Nova Scotia Health Authority (Central Zone)"},{"name":"Department of Pathology, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Pasternak","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Department of Pathology, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thai Yen","family":"Ly","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Department of Pathology, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Requena","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, University Hospital La Princesa, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Kutzner","sequence":"additional","affiliation":[{"name":"Dermatopathology Friedrichshafen, Friedrichshafen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Chott","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Microbiology, Wilhelminenspital, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Cerroni","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Research Unit Dermatopathology, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/01.dad.0000211513.98230.74","article-title":"Soft tissue amyloidoma of the extremities. Report of a case and review of literature","volume":"29","author":"Pasternak","year":"2007","journal-title":"Am J Dermatopathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archderm.139.9.1157","article-title":"Nodular amyloidoisis. Review and long-term follow-up of 16 cases","volume":"139","author":"Moon","year":"2003","journal-title":"Arch Dermatol"},{"key":"R4-20230922","first-page":"A4727","article-title":"Primary localized cutaneous amyloidosis\u2014systematic review","volume":"60","author":"Kaltoft","year":"2013","journal-title":"Dan Med J"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1590\/S0365-05962011000500018","article-title":"Localized primary cutaneous nodular amyloidosis\u2014case report","volume":"86","author":"De Souza","year":"2011","journal-title":"An Bras Dermatol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/03009734.2012.654861","article-title":"Localized AL amyloidosis: a suicidal neoplasm?","volume":"117","author":"Westermark","year":"2012","journal-title":"Ups J Med Sci"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.blre.2015.12.001","article-title":"Monoclonal gammopathy: the good, the bad and the ugly","volume":"30","author":"Glavey","year":"2016","journal-title":"Blood Rev"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","article-title":"New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells","volume":"110","author":"Perez-Persona","year":"2007","journal-title":"Blood"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archderm.1970.04000070010002","article-title":"The cutaneous amyloidoses. I. Localized forms","volume":"102","author":"Brownstein","year":"1970","journal-title":"Arch Dermatol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2133.2001.04291.x","article-title":"Nodular localized primary cutaneous amyloidosis: a long term follow-up study","volume":"145","author":"Woolons","year":"2001","journal-title":"Br J Dematol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/S2352-3026(15)00068-X","article-title":"Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study","volume":"2","author":"Mahmood","year":"2015","journal-title":"Lancet Haematol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/art.23617","article-title":"Sjogren\u2019s syndrome and localized nodular cutaneous amyloidosis. Coincidence or a distinct clinical entity?","volume":"58","author":"Meijer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/PAS.0b013e318272fe19","article-title":"Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder","volume":"37","author":"Grogg","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ajcp\/100.2.135","article-title":"Tumoral presentation of amyloidosis (amyloidomas) in soft tissues. A report of 14 cases","volume":"100","author":"Krishnan","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"634","DOI":"10.5732\/cjc.009.10627","article-title":"Primary cutaneous marginal zone B-cell lymphoma with amyloid deposition: report of two cases with review of literature","volume":"29","author":"Zhang","year":"2010","journal-title":"Chin J Cancer"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-4632.2010.04524.x","article-title":"Nodular localized primary cutaneous amyloidosis and primary marginal zone B-cell lymphoma on the nose: treatment with microscopically controlled surgery","volume":"50","author":"Kendler","year":"2011","journal-title":"Int J Dermatol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1309\/AJCPI08WAKYVLHHA","article-title":"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloid deposition. A clinicopathologic case series","volume":"137","author":"Ryan","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/jcp.54.8.642","article-title":"Pulmonary marginal zone lymphoma of MALT type as a cause of localized pulmonary amyloidosis","volume":"54","author":"Lim","year":"2001","journal-title":"J Clin Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jcp.56.1.74","article-title":"Low grade marginal zone B-cell lymphoma of the breast associated with localised amyloidosis and corpora amylacea in a woman with long standing primary Sjogren\u2019s syndrome","volume":"56","author":"Kambouchner","year":"2003","journal-title":"J Clin Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ajcp\/111.1.111","article-title":"Extramedullary plasmacytoma. A form of marginal zone cell lymphoma?","volume":"111","author":"Hussong","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R24-20230922","first-page":"1234","article-title":"The phenotype of normal, reactive and malignant plasma cells. Identification of \u201cmany and multiple myelomas\u201d and of new targets for myeloma therapy","volume":"91","author":"Bataille","year":"2006","journal-title":"Haematologica"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ajh.21814","article-title":"Two distinct syndromes of lymphoma associated AL amyloidosis: a case series and review of the literature","volume":"85","author":"Telio","year":"2010","journal-title":"Am J Hematol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/ard.2005.044362","article-title":"Lymphoma and other malignancies in primary Sjogren\u2019s syndrome. Editorial","volume":"65","author":"Pillemer","year":"2006","journal-title":"Ann Rheum Dis"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201708000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:37:54Z","timestamp":1695422274000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201708000-00008"}},"subtitle":["Cutaneous Amyloidosis, Plasma Cell Dyscrasia or a Manifestation of Primary Cutaneous Marginal Zone Lymphoma?"],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000861","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}